OPTIMIZATION OF POSTOPERATIVE MANAGEMENT IN PATIENTS AFTER HYSTEROSCOPY

Objective. To prevent infectious complications after hysteroscopy on early hospital discharge. Subjects and methods. Seventy patients who had undergone therapeutic and diagnostic hysteroscopy in inpatient settings were examined. To prevent postoperative infectious complications, the combined drug safocid was used on the day of hysteroscopy and, if there was a high infectious risk, reused on day 7 after surgery. The results were compared with those obtained from the patients who traditionally received prophylactic antibiotic therapy with second-to-third-generation cephalosporins for 5—7 days. Effectiveness was evaluated from clinical data, analyses of blood, vaginal smears, and Toll-receptor expression. Results. The postoperative period was complicated by an inflammatory process in none of the examined patients, which suggests that safocid is highly effective in preventing infectious complications after hysteroscopy and that it is comparable with a course of cephalosporin therapy. Laboratory and special studies confirm its clinical effect. Conclusion. When safocid is administered to prevent inflammatory complications after hysteroscopy, there may be an early hospital discharge and there is no need for any additional use of antifungal drugs.

hysteroscopy, postoperative period, infectious complications, safocid, early discharge